Pro-Dex, Inc. (PDEX) financial statements (2021 and earlier)
Company profile
Business Address |
2361 MCGAW AVENUE IRVINE, CA 92614 |
State of Incorp. | CA |
Fiscal Year End | June 30 |
SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 9,715 | 10,391 | 7,408 | 4,205 | 2,294 | 697 | 3,188 | ||
Cash and cash equivalents | 6,175 | 7,742 | 5,188 | 4,205 | 2,294 | 697 | 3,188 | ||
Short-term investments | 3,540 | 2,649 | 2,220 | ||||||
Receivables | 2,683 | 4,100 | 4,131 | 3,624 | 2,979 | 3,207 | 2,880 | ||
Inventory, net of allowances, customer advances and progress billings | 7,808 | 6,239 | 4,393 | 3,085 | 3,573 | 4,310 | 2,600 | ||
Inventory | 7,808 | 6,239 | 4,393 | 3,085 | 3,573 | 4,310 | 2,600 | ||
Prepaid expense | 277 | 134 | 124 | 110 | |||||
Deferred costs | 492 | 430 | 32 | 12 | 238 | ||||
Deferred tax assets | ✕ | 70 | 115 | ||||||
Other undisclosed current assets | 193 | 623 | 269 | 718 | |||||
Total current assets: | 20,891 | 21,783 | 16,233 | 11,921 | 9,218 | 8,408 | 8,893 | ||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 3,107 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
Property, plant and equipment | 2,768 | 2,726 | 1,755 | 1,429 | 1,286 | 1,470 | 1,575 | ||
Long-term investments and receivables | 1,610 | 582 | 43 | 450 | 1,058 | ||||
Long-term investments | 1,610 | 582 | 1,058 | ||||||
Accounts and financing receivable, after allowance for credit loss | 43 | 450 | |||||||
Intangible assets, net (including goodwill) | 145 | 129 | 140 | 432 | 563 | 900 | 105 | ||
Goodwill | 112 | 112 | 353 | ||||||
Intangible assets, net (excluding goodwill) | 145 | 129 | 140 | 320 | 451 | 547 | 105 | ||
Other noncurrent assets | 42 | 40 | 68 | 71 | 80 | 86 | 77 | ||
Other undisclosed noncurrent assets | 163 | 260 | 1,678 | 2,048 | 1,652 | ||||
Total noncurrent assets: | 7,835 | 3,737 | 3,684 | 4,430 | 1,929 | 4,108 | 2,815 | ||
TOTAL ASSETS: | 28,726 | 25,520 | 19,917 | 16,351 | 11,147 | 12,516 | 11,708 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 2,959 | 3,595 | 2,472 | 2,503 | 1,839 | 3,407 | 2,127 | ||
Accounts payable | 1,672 | 1,996 | 1,083 | 1,159 | 841 | 1,867 | 744 | ||
Accrued liabilities | 1,287 | 1,437 | 1,266 | 1,344 | 997 | 1,202 | 1,090 | ||
Employee-related liabilities | 302 | 240 | |||||||
Taxes payable | 162 | 123 | 1 | 36 | 53 | ||||
Deferred revenue | 360 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
Debt | 633 | 622 | 35 | 58 | 26 | 31 | 8 | ||
Deferred revenue and credits | ✕ | ✕ | 19 | 212 | 594 | 232 | |||
Other undisclosed current liabilities | 53 | 31 | (338) | (240) | |||||
Total current liabilities: | 3,952 | 4,270 | 2,538 | 2,580 | 2,077 | 3,694 | 2,127 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation, including: | 3,613 | 3,934 | 6 | 61 | 46 | 70 | 7 | ||
Long-term debt, excluding current maturities | 46 | 70 | |||||||
Capital lease obligations | ✕ | 6 | 7 | ||||||
Operating lease, liability | 2,937 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
Other undisclosed long-term debt and lease obligation | 676 | 3,934 | 61 | ||||||
Liabilities, other than long-term debt | 352 | 146 | 97 | 147 | 274 | 358 | |||
Deferred revenue and credits | ✕ | ✕ | 147 | 204 | 243 | ||||
Accounts payable and accrued liabilities | 352 | ||||||||
Deferred rent credit | 146 | 97 | ✕ | ✕ | ✕ | ✕ | |||
Deferred tax liabilities, net | ✕ | 70 | 115 | ||||||
Other undisclosed noncurrent liabilities | 2,937 | 162 | |||||||
Total noncurrent liabilities: | 6,902 | 4,242 | 103 | 61 | 193 | 344 | 365 | ||
Total liabilities: | 10,854 | 8,512 | 2,641 | 2,641 | 2,270 | 4,038 | 2,492 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent | 17,872 | 17,008 | 17,276 | 13,710 | 8,877 | 8,478 | 9,216 | ||
Common stock | 13,634 | 15,815 | 19,835 | 17,704 | 17,988 | 18,411 | 18,582 | ||
Accumulated other comprehensive income (loss) | 100 | (549) | (153) | 33 | 202 | ||||
Retained earnings (accumulated deficit) | 4,138 | 1,742 | (2,406) | (4,027) | (9,111) | (9,933) | (9,568) | ||
Total stockholders' equity: | 17,872 | 17,008 | 17,276 | 13,710 | 8,877 | 8,478 | 9,216 | ||
TOTAL LIABILITIES AND EQUITY: | 28,726 | 25,520 | 19,917 | 16,351 | 11,147 | 12,516 | 11,708 |
Income statement (P&L) ($ in thousands)
12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 29,059 | 27,172 | 22,465 | 21,943 | 20,158 | 13,383 | 10,812 | |
Revenue, net | ✕ | ✕ | 21,943 | 20,158 | 13,383 | 10,812 | ||
Cost of revenue | (18,610) | (17,392) | (14,522) | (14,757) | (14,755) | (9,679) | (7,846) | |
Gross profit: | 10,449 | 9,780 | 7,943 | 7,186 | 5,403 | 3,704 | 2,966 | |
Operating expenses | (5,213) | (4,782) | (5,551) | (4,452) | (4,877) | (4,606) | (3,780) | |
Operating income (loss): | 5,236 | 4,998 | 2,392 | 2,734 | 526 | (902) | (814) | |
Nonoperating income (expense) | (66) | 449 | 218 | 18 | 321 | 456 | 59 | |
Investment income, nonoperating | 161 | 624 | 225 | 27 | 6 | |||
Other nonoperating income | 12 | |||||||
Interest and debt expense | (253) | (220) | (7) | (12) | (37) | (6) | (8) | |
Income (loss) from continuing operations before equity method investments, income taxes: | 4,917 | 5,227 | 2,603 | 2,740 | 810 | (452) | (763) | |
Other undisclosed income from continuing operations before income taxes | 279 | 220 | 7 | 12 | 37 | 6 | 8 | |
Income (loss) from continuing operations before income taxes: | 5,196 | 5,447 | 2,610 | 2,752 | 847 | (446) | (755) | |
Income tax expense (benefit) | (1,223) | (1,299) | (989) | 2,089 | (25) | 44 | 104 | |
Income (loss) from continuing operations: | 3,973 | 4,148 | 1,621 | 4,841 | 822 | (402) | (651) | |
Income from discontinued operations | 243 | 37 | 163 | |||||
Net income (loss) available to common stockholders, diluted: | 3,973 | 4,148 | 1,621 | 5,084 | 822 | (365) | (488) |
Comprehensive Income ($ in thousands)
12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | 3,973 | 4,148 | 1,621 | 5,084 | 822 | (365) | (488) | |
Other comprehensive loss | (22) | |||||||
Other undisclosed comprehensive income | 197 | |||||||
Comprehensive income (loss): | 3,973 | 4,148 | 1,621 | 5,062 | 822 | (365) | (291) | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 448 | (396) | (186) | 55 | ||||
Comprehensive income (loss), net of tax, attributable to parent: | 4,421 | 3,752 | 1,435 | 5,117 | 822 | (365) | (291) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.